Skip to content
10-Q

Quarterly Report

Prevail Therapeutics Inc.

0001564590-20-039115

← back to feed
Filed
Aug 11, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Aug 5, 2020 34.21M sh
Capex Q2 2020 · Jun 30, 2020 $374K
Capex Q2 2020 · Jun 30, 2019 $1.54M
Operating Cash Flow Q2 2020 · Jun 30, 2020 −$36.59M
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$22.45M
Short Term Investments Q2 2020 · Jun 30, 2020 $6.46M
Short Term Investments Q2 2020 · Dec 31, 2019 $0
Cash And Equivalents Q2 2020 · Jun 30, 2020 $111.07M
Cash And Equivalents Q2 2020 · Dec 31, 2019 $168.05M
Cash And Equivalents Q2 2020 · Jun 30, 2019 $202.1M
Stockholders Equity Q2 2020 · Jun 30, 2020 $128.66M
Stockholders Equity Q2 2020 · Mar 31, 2020 $148.46M
Stockholders Equity Q2 2020 · Dec 31, 2019 $165.34M
Stockholders Equity Q2 2020 · Jun 30, 2019 $201.04M
Stockholders Equity Q2 2020 · Mar 31, 2019 −$27.75M
Stockholders Equity Q2 2020 · Dec 31, 2018 −$18.42M
Current Liabilities Q2 2020 · Jun 30, 2020 $12.86M
Current Liabilities Q2 2020 · Dec 31, 2019 $11.83M
Total Liabilities Q2 2020 · Jun 30, 2020 $22.04M
Total Liabilities Q2 2020 · Dec 31, 2019 $21.76M
Current Assets Q2 2020 · Jun 30, 2020 $122.14M
Current Assets Q2 2020 · Dec 31, 2019 $174.46M
Total Assets Q2 2020 · Jun 30, 2020 $150.69M
Total Assets Q2 2020 · Dec 31, 2019 $187.1M
Sga Expense Q2 2020 · Jun 30, 2020 $9.21M
Sga Expense Q2 2020 · Jun 30, 2020 $17.07M
Sga Expense Q2 2020 · Jun 30, 2019 $3.71M
Sga Expense Q2 2020 · Jun 30, 2019 $5.6M
Rd Expense Q2 2020 · Jun 30, 2020 $12.94M
Rd Expense Q2 2020 · Jun 30, 2020 $24.36M
Rd Expense Q2 2020 · Jun 30, 2019 $11.96M
Rd Expense Q2 2020 · Jun 30, 2019 $20.37M
Net Income Q2 2020 · Jun 30, 2020 −$22.1M
Net Income Q2 2020 · Jun 30, 2020 −$40.68M
Net Income Q2 2020 · Jun 30, 2019 −$15.1M
Net Income Q2 2020 · Jun 30, 2019 −$25.05M
Operating Income Q2 2020 · Jun 30, 2020 −$22.15M
Operating Income Q2 2020 · Jun 30, 2020 −$41.43M
Operating Income Q2 2020 · Jun 30, 2019 −$15.67M
Operating Income Q2 2020 · Jun 30, 2019 −$25.96M